Nuked 
Hello, tech lovers! Today, we’re diving into an exciting story about Samsung and a rising star in medical tech, Exo.
In a move that could shake up healthcare innovation, Samsung is eyeing a big investment in Exo, a California-based startup specializing in handheld medical imaging devices. The round might reach up to $100 million, according to Bloomberg’s sources.
This funding round is led by Sands Capital, Bold Capital, and Qubit Health Capital. Interestingly, Imar Ishrak from Qubit will join Exo’s board, signaling strong confidence. Born in 2015, Exo develops AI-powered ultrasound devices that connect to smartphones, allowing quick and efficient imaging like lung scans and cardiac exams.
The company has already attracted over $320 million from prominent investors like RA Capital, BlackRock, and Intel, among others. Their latest round was a hefty $220 million Series C in 2021. They also may team up with Samsung Medison, a leader in ultrasound diagnostics and X-ray systems.
While Exo’s technology is revolutionary—enabling medical exams, documentation, and sharing reports via a single app—they haven’t commented on this potential investment yet. The story highlights how innovation in medical devices continues to accelerate, fueled by giants like Samsung backing promising startups.
